Literatur
- 1
UK Prospective Diabetes Study (UKPDS) Group .
Intensive blood-glucose control with sulfonylureas or insulin compared with conventional
treatment and risk of complications in patients with type-2 diabetes. (UKPDS 33).
Lancet.
1998;
352
837-853
- 2
Shichiri M, Kishikawa H, Ohkubo Y et al.
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic
patients.
Diabetes Care.
2000;
23 (Suppl. 2)
B 21-B 29
- 3
The Action to Control Cardiovascular Risk in Diabetes Study Group .
Effect of intensive glucose lowering in type 2 diabetes.
N Eng J Med.
2008;
358
2545-2559
- 4
The ADVANCE Collaborative Group .
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
N Eng J Med.
2008;
358
2560-2572
- 5
Patel A, McMahon S The ADVANCE Collaborative Group et al.,.
Effect of a fixed combination of perindopril and indapamide on macrovascular and microvascular
outcomes in patients with type 2 diabetes mellitus.
Lancet.
2007;
370
829-840
- 6
Dluhy R G, McMahon G T.
Intensive glycemic control in the ACCORD and ADVANCE trials.
N Eng J Med.
2008;
358
2630-2633
- 7
UKPDS Group .
Effect of intensive blood-glucose control with metformin on complications in overweight
patients with type 2 diabetes (UKPDS 34).
Lancet.
1998;
352
854-865
Prof. Dr. med. S. Matthaei
Diabetes-Zentrum Quakenbrück · Christliches Krankenhaus Quakenbrück
Danziger Straße 10
49610 Quakenbrück
Email: s.matthaei@christliches-krankenhaus-ev.de
